Patients with leptomeningeal metastasis face a difficult choice for delivering chemotherapy. They can use an Ommaya reservoir or undergo repeated lumbar punctures. A recent meta-analysis looked at four studies to compare these two methods. The goal was to see if one approach truly helps people live longer or feel better.
The analysis found that using an Ommaya reservoir for intrathecal chemotherapy was linked to significantly better overall survival. The data showed a strong benefit for patients receiving treatment through this device compared to those getting injections via lumbar puncture.
Side effects were also a key concern. The study estimated that overall adverse events were numerically lower in the Ommaya group. This suggests the reservoir might be easier on the body. However, the researchers noted that safety data came from non-comparative sources and should be treated cautiously.
The quality of the included studies varied. Some had moderate risk of bias, and the data on disease control showed some inconsistency. Despite these limits, the findings offer further evidence for clarifying the advantages of the Ommaya reservoir in clinical practice.
